Patent intelligence · NZ
NZ 743471
Improved immunoglobulin variable domains
Improved immunoglobulin variable domains
Patent details — NZ 743471
- Jurisdiction
- NZ
- Status
- granted
- Grant date
- Jul 26, 2024
- Expiration
- Jul 21, 2044
- Applicant
- ABLYNX NV
- CPC classes
- A61P/3702
Quick answer
NZ 743471 (Improved immunoglobulin variable domains) is held by ABLYNX NV. Status: granted. Granted Jul 26, 2024. Expires Jul 21, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ABLYNX NV
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P/3702
More from ABLYNX NV
Related pharmaceutical patents in our USPTO index.
-
WO 2026078159
AGENTS D'ACTIVATION DE CELLULES IMMUNITAIRES ET PROCÉDÉS LES COMPRENANT
granted -
WO 2026030375
NANOPARTICULES LIPIDIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
granted -
WO 2025262150
MOLÉCULES DE RECRUTEMENT D'ANTICORPS
granted -
AR 133055
DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA DIRIGIDOS A PD-L1
granted -
MX 2025007399
PROTEIN-BASED CONJUGATION CARRIERS
granted -
WO 2025133166
VÉHICULES À BASE DE PROTÉINES POUR CONJUGAISON D'AMINE SPÉCIFIQUE À UN SITE
granted -
WO 2025133252
DOMAINES VARIABLES UNIQUES D'IMMUNOGLOBULINE CIBLANT CEACAM5
granted -
WO 2025133253
EXCIPIENTS DE CONJUGAISON PROTÉINIQUES POUR ADMINISTRATION INTRANUCLÉAIRE
granted
Frequently asked questions
What is US patent 743471?
NZ 743471 (Improved immunoglobulin variable domains) is held by ABLYNX NV. Status: granted. Granted Jul 26, 2024. Expires Jul 21, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns NZ 743471?
ABLYNX NV is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does NZ 743471 expire?
Our index shows an expiration date of Jul 21, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.